Targeting TYK2 in brain seen as potential strategy for MS treatment

Targeting TYK2 in brain seen as potential strategy for MS treatment

A small molecule that blocks the activity of a protein called TYK2 in the brain showed promise at reducing disease activity in mouse models of multiple sclerosis (MS), according to a study. The study was conducted by Neuron23, which is advancing a small molecule TYK2 inhibitor called NEU-627 to treat MS. That molecule is expected […] The post Targeting TYK2 in brain seen as potential strategy for MS treatment appeared first on Multiple Sclerosis…